INCIDENCE OF ACUTE MYOCARDIAL INFARCTION IN THE PERIOD OF 2017-2019 AT THE UNIVERSITY CLINIC OF CARDIOLOGY, SKOPJE, NORTH MACEDONIA

Authors

  • Monika Trpeska PHI "University Clinic of Cardiology", Skopje, North Macedonia
  • Gordana Kamceva Mihailova Faculty of Medical Sciences, Goce Delcev University, Stip, North Macedonia

Keywords:

acute myocardial infarction, percutaneous coronary intervention, coronary bypass surgery

Abstract

Acute myocardial infarction (AMI) is defined as necrosis of cardiac myocytes with symptoms of acute myocardial ischemia, with an increase and/or decrease in the level of cardiac biomarkers, mainly high sensitivity cardiac troponin and at least one other criterion: symptoms of ischemia, new or significant changes in the ST T segment of the electrocardiogram (ECG), development of pathologic Q waves on the ECG, evidence from imaging techniques, and/or intracoronary thrombus detected at angiography or autopsy. The main purpose of the paper is to present the patients with acute myocardial infarction within three consecutive years, divided according to method of treatment. The data were taken from the University Clinic of Cardiology Skopje, retrogradely, during three consecutive years from 2017 2019. In 2017, out of a total of 767 patients with AMI, 722 patients (94.13%) were stented with percutaneous coronary intervention (PCI), and 12 patients had multivessel disease and were referred for coronary bypass surgery (CABP), while 33 patients were treated with medication. In 2018, 1098 patients were admitted, of which 1054 were stented (95.99%), 12 patients were referred to ACBP, and 32 patients were treated with medical treatment. In 2019, 1082 patients were admitted, of which 1039 patients were stented (96.02%), 18 patients were referred for ACBP and 24 patients were treated medically. Most of the patients were treated with percutaneous coronary interventions with stenting of the culprit lesion, and a smaller part with multivessel disease were referred for ACBP. Those patients who visited the doctor >48 hours from the onset of pain were treated with drug therapy.

References

Barcelona R. (2022). Best Practices in Pharmacotherapy for Acute Coronary Syndromes. US Cardiology Review, 16:e16.

GBD 2017 Causes of Death Collaborators. (2017). Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392:1736–1788. https://doi.org/10.1016/s0140-6736(18)32203-7

Lee SH, Hong YJ, Ahn Y, Jeong MH (2023). Past, Present, and Future of Management of Acute Myocardial Infarction. J Cardiovasc Interv. 2(2):51-65. https://doi.org/10.54912/jci.2022.0023

Roffi M. (2023) What Is New in the 2023 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndromes. Cardiology Discovery 3:4, 227-231.

Kim, S.Y., Lee, JP., Shin, WR. et al. (2022). Cardiac biomarkers and detection methods for myocardial infarction. Mol. Cell. Toxicol. 18, 443–455. https://doi.org/10.1007/s13273-022-00287-1

Kristian Thygesen, Joseph S Alpert, Allan S Jaffe, Bernard R Chaitman, Jeroen J Bax, David A Morrow, Harvey D White, ESC Scientific Document Group. (2019). Fourth universal definition of myocardial infarction, European Heart Journal, Volume 40, Issue 3, 14 January 2019, Pages 237–269, https://doi.org/10.1093/eurheartj/ehy462

Pedicino D, Liuzzo G. (2023) Does MULTISTARS shed light on the timing of complete revascularization in ST-elevation myocardial infarction?. European Heart Journal 389.

Robert A Byrne, Xavier Rossello, J J Coughlan, Emanuele Barbato, Colin Berry, Alaide Chieffo, Marc J Claeys, Gheorghe-Andrei Dan, Marc R Dweck, Mary Galbraith, Martine Gilard, Lynne Hinterbuchner, Ewa A Jankowska, Peter Jüni, Takeshi Kimura, Vijay Kunadian, Margret Leosdottir, Roberto Lorusso, Roberto F E Pedretti, Angelos G Rigopoulos, Maria Rubini Gimenez, Holger Thiele, Pascal Vranckx, Sven Wassmann, Nanette Kass Wenger, Borja Ibanez, ESC Scientific Document Group. (2023). ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC), European Heart Journal, Volume 44, Issue 38, 7 October 2023, Pages 3720–3826, https://doi.org/10.1093/eurheartj/ehad191

Sun B, Wang L, Guo W, Chen S, Ma Y, Wang D. (2023). New treatment methods for myocardial infarction. Front Cardiovasc Med. 28;10:1251669. doi: 10.3389/fcvm.2023.1251669. PMID: 37840964; PMCID: PMC10569499.

Timmis A, Vardas P, Townsend N, Torbica A, Katus H, De Smedt D, et al. (2022). European Society of Cardiology: cardiovascular disease statistics 2021. Eur Heart J 2022; 43:716–799. https://doi.org/10.1093/eurheartj/ehab892

Tsai TY, W Serruys P. (2023) Complete revascularization for acute coronary syndrome, one step at a time. Cardiovascular Research 119:15, e152-e154.

Downloads

Published

2023-12-10

How to Cite

Trpeska, M., & Kamceva Mihailova, G. (2023). INCIDENCE OF ACUTE MYOCARDIAL INFARCTION IN THE PERIOD OF 2017-2019 AT THE UNIVERSITY CLINIC OF CARDIOLOGY, SKOPJE, NORTH MACEDONIA. KNOWLEDGE - International Journal , 61(4), 527–529. Retrieved from https://ikm.mk/ojs/index.php/kij/article/view/6447

Most read articles by the same author(s)

1 2 > >>